Dr. Brian Timothy Hess, MD

Dr. Hess practices at MUSC University Hospital in Charleston, South Carolina.

Dr. Hess' NPI, 1770898900, was assigned on August 12, 2010. Dr. Hess graduated from University of Missouri, Columbia School of Medicine in 2010. Dr. Hess holds South Carolina license 39373.

Dr. Hess' primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Dr. Hess' primary practice is MUSC University Hospital in Charleston, South Carolina. Dr. Hess is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Hess to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hess practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hess' primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Hess' licenses on file in 3 states: South Carolina, Illinois and Missouri.

CMS data shows 509 Medicare services from Dr. Hess across 7 procedure codes in 2024, for 274 Medicare patients. Medicare paid $38,898 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 274 Medicare patients who saw Dr. Hess in 2024. The largest group is 65 to 74, with 139 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 5% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hess' median patient age at 67, with 44% women.

In 2024, Dr. Hess wrote 385 Medicare Part D claims for 99 patients. 59% of them were for generic drugs. CMS names the drug for 251 of them, across 8 drugs with 11 or more claims each, at $1,397,027 in total drug cost. In 2023, CMS named 255 claims across 9 drugs.

Dr. Hess accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Hess, published from 2010 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse and Receptors, Chimeric Antigen. Dr. Hess has published most often in Blood Adv. Dr. Hess' most frequent co-authors are Brad Steven Kahl, MD, Pallawi Torka, MD and Juan Pablo Alderuccio, MD.

Dmand AI links Dr. Hess to 10 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Hodgkin Disease and Lymphoma, B-Cell, Marginal Zone. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 40 general payments to Dr. Hess from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Celgene Corporation paid the most, $10,169. It also lists 3 research payments totaling $4,470 from 2024 to 2025.

Dr. Hess graduated from University of Missouri, Columbia School of Medicine in 2010.